We thank Zhou et al1 for their thoughtful review of our paper and for highlighting issues that are central to interpreting gene-specific adenoma risks in Lynch syndrome (LS).2 We appreciate their interest and the opportunity to clarify several points already addressed in the paper.
We will be happy to hear your thoughts